Literature DB >> 16150255

Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.

Kristina Elfgren1, Eva Rylander, Thomas Rådberg, Björn Strander, Anders Strand, Kirsti Paajanen, Inga Sjöberg, Walter Ryd, Ilvars Silins, Joakim Dillner.   

Abstract

OBJECTIVE: Evaluation of colposcopic and histopathological findings in women screened for cervical human papillomavirus deoxyribonucleic acid persistence. STUDY
DESIGN: A total of 12 527 women, aged 32 to 38 years old, attending the population-based cervical cancer screening program in Sweden were randomized 1:1 to mock testing or human papillomavirus deoxyribonucleic acid testing by general primer 5+/6+ polymerase chain reaction and subsequent typing. Human papillomavirus deoxyribonucleic acid-positive women with a normal Papanicolaou smear (n=341) and an equal number from the control group were human papillomavirus tested on average 19 months later. One hundred nineteen women with type-specific human papillomavirus persistence and 111 controls were referred to colposcopy, and 84.8% attended.
RESULTS: Histopathology from colposcopically directed biopsies confirmed cervical intraepithelial neoplasia grade 2 or 3 in 28 of 100 of the women with human papillomavirus deoxyribonucleic acid persistence and in 2 of 95 among controls.
CONCLUSION: Among women with normal Papanicolaou smear attending population-based screening, the positive predictive value of human papillomavirus deoxyribonucleic acid persistence for detection of biopsy-confirmed cervical intraepithelial neoplasia 2 or 3 was 29%.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150255     DOI: 10.1016/j.ajog.2005.01.056

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

Review 1.  Primary HPV screening for cervical cancer prevention: results from European trials.

Authors:  Elsebeth Lynge; Matejka Rebolj
Journal:  Nat Rev Clin Oncol       Date:  2009-11-10       Impact factor: 66.675

2.  Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screening.

Authors:  M Rebolj; E Lynge
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

3.  RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.

Authors:  Paola Cattani; Alessia Siddu; Sara D'Onghia; Simona Marchetti; Rosaria Santangelo; Valerio G Vellone; Gian Franco Zannoni; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

4.  Screening adolescents and young women.

Authors:  Lori A Boardman; Katina Robison
Journal:  Obstet Gynecol Clin North Am       Date:  2013-04-17       Impact factor: 2.844

5.  Major clinical research advances in gynecologic cancer 2009.

Authors:  Kidong Kim; Sang-Young Ryu
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

6.  Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition.

Authors:  Jae Kwan Lee; Jin Hwa Hong; Sokbom Kang; Dae-Yeon Kim; Byoung-Gie Kim; Sung-Hoon Kim; Yong-Man Kim; Jae-Weon Kim; Jae-Hoon Kim; Tae-Jin Kim; Hyun Jung Kim; Hye Sun Kim; Hee-Sug Ryu; Jae Yun Song; Hyeong Sik Ahn; Chong Woo Yoo; Hye-Kyoung Yoon; Keun-Ho Lee; Ahwon Lee; Yonghee Lee; In Ho Lee; Jeong-Won Lee; Taek Sang Lee; Myong Cheol Lim; Suk-Joon Chang; Hyun Hoon Chung; Woong Ju; Hee Jae Joo; Soo-Young Hur; Sung-Ran Hong; Joo-Hyun Nam
Journal:  J Gynecol Oncol       Date:  2013-04-05       Impact factor: 4.401

7.  New insights into cervical cancer screening.

Authors:  Jonathan D Boone; Britt K Erickson; Warner K Huh
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

8.  Inference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approach.

Authors:  Helen C Johnson; K Miriam Elfström; W John Edmunds
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

9.  Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.

Authors:  Joakim Dillner; Matejka Rebolj; Philippe Birembaut; Karl-Ulrich Petry; Anne Szarewski; Christian Munk; Silvia de Sanjose; Pontus Naucler; Belen Lloveras; Susanne Kjaer; Jack Cuzick; Marjolein van Ballegooijen; Christine Clavel; Thomas Iftner
Journal:  BMJ       Date:  2008-10-13

10.  HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study.

Authors:  P Naucler; W Ryd; S Törnberg; A Strand; G Wadell; B G Hansson; E Rylander; J Dillner
Journal:  Br J Cancer       Date:  2007-06-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.